Ellington Management Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-1,500
| Closed | -$349K | – | 499 |
|
2019
Q3 | $349K | Sell |
1,500
-2,300
| -61% | -$535K | 0.06% | 303 |
|
2019
Q2 | $889K | Buy |
+3,800
| New | +$889K | 0.15% | 133 |
|
2019
Q1 | – | Sell |
-1,200
| Closed | -$361K | – | 541 |
|
2018
Q4 | $361K | Buy |
+1,200
| New | +$361K | 0.11% | 188 |
|
2018
Q3 | – | Sell |
-700
| Closed | -$203K | – | 510 |
|
2018
Q2 | $203K | Sell |
700
-1,000
| -59% | -$290K | 0.01% | 403 |
|
2018
Q1 | $465K | Buy |
+1,700
| New | +$465K | 0.03% | 418 |
|
2017
Q3 | – | Sell |
-3,000
| Closed | -$814K | – | 633 |
|
2017
Q2 | $814K | Buy |
3,000
+800
| +36% | +$217K | 0.12% | 117 |
|
2017
Q1 | $602K | Hold |
2,200
| – | – | 0.02% | 250 |
|
2016
Q4 | $624K | Buy |
+2,200
| New | +$624K | 0.1% | 159 |
|
2014
Q4 | – | Sell |
-1,300
| Closed | -$430K | – | 563 |
|
2014
Q3 | $430K | Buy |
+1,300
| New | +$430K | 0.3% | 70 |
|
2013
Q3 | – | Sell |
-1,400
| Closed | -$301K | – | 766 |
|
2013
Q2 | $301K | Buy |
+1,400
| New | +$301K | 0.06% | 511 |
|